Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

July 10, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Deep Vein ThrombosisPost-thrombotic Syndrome
Interventions
DEVICE

EkoSonic® Endovascular System

BIOLOGICAL

Alteplase

Recombinant tissue plasminogen activator

Trial Locations (22)

10016

NYU Langone Medical Center, New York

10024

Weill Cornell Medical Center, New York

19718

Christiana Hospital, Newark

22304

Inova Alexandria Hospital, Alexandria

23507

Sentara Norfolk General Hospital, Norfolk

30309

Piedmont Atlanta Hospital, Atlanta

31201

Medical Center of Central Georgia, Macon

33606

Tampa General Hospital, Tampa

40202

University of Louisville Research Foundation, Louisville

43130

Fairfield Medical Center, Lancaster

44708

Aultman Hospital, Canton

48109

University of Michigan Medical Center, Ann Arbor

68510

CHI Health St. Elizabeth, Lincoln

70121

Ochsner Medical Center, New Orleans

75208

DFW Vascular Group/ Methodist Dallas Medical Ctr, Dallas

77479

Houston Methodist Sugar Land Hospital, Sugar Land

80045

University of Colorado Hospital, Aurora

90024

UCLA Medical Center, Los Angeles

97239

Oregon Health & Science University, Portland

06820

Vascular Breakthroughs, Darien

04106

Maine Medical Center, Portland

07666

Holy Name Medical Center, Teaneck

Sponsors
All Listed Sponsors
collaborator

EKOS Corporation

INDUSTRY

lead

Boston Scientific Corporation

INDUSTRY